Relation Therapeutics secured a collaboration with GSK to generate large-scale cellular perturbation data for cellular foundation models, with potential payments up to $110 million. The deal centers on building high-throughput, automated laboratory outputs intended to train MORGAN, Relation’s general-purpose multi-omic cellular model designed to predict responses to genetic and pharmacological interventions across cell types and disease areas.